Your browser doesn't support javascript.
loading
High-level Gpr56 expression is dispensable for the maintenance and function of hematopoietic stem and progenitor cells in mice.
Rao, Tata Nageswara; Marks-Bluth, Jonathan; Sullivan, Jessica; Gupta, Manoj K; Chandrakanthan, Vashe; Fitch, Simon R; Ottersbach, Katrin; Jang, Young C; Piao, Xianhua; Kulkarni, Rohit N; Serwold, Thomas; Pimanda, John E; Wagers, Amy J.
Afiliação
  • Rao TN; Howard Hughes Medical Institute, USA; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA; Joslin Diabetes Center, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
  • Marks-Bluth J; Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW 2052, Australia; Prince of Wales Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
  • Sullivan J; Howard Hughes Medical Institute, USA; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA; Joslin Diabetes Center, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
  • Gupta MK; Joslin Diabetes Center, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
  • Chandrakanthan V; Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW 2052, Australia; Prince of Wales Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
  • Fitch SR; Department of Haematology, Cambridge Institute for Medical Research University of Cambridge, Cambridge CB2 0XY, UK; Wellcome Trust - Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UK.
  • Ottersbach K; Department of Haematology, Cambridge Institute for Medical Research University of Cambridge, Cambridge CB2 0XY, UK; Wellcome Trust - Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge CB2 0XY, UK.
  • Jang YC; Howard Hughes Medical Institute, USA; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA; Joslin Diabetes Center, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
  • Piao X; Division of Newborn Medicine, Boston Children's Hospital, Harvard Medical School, MA, USA.
  • Kulkarni RN; Joslin Diabetes Center, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
  • Serwold T; Joslin Diabetes Center, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA.
  • Pimanda JE; Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW 2052, Australia; Prince of Wales Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.
  • Wagers AJ; Howard Hughes Medical Institute, USA; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA; Joslin Diabetes Center, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02215, USA. Electronic address: amy_wagers@harvard.edu.
Stem Cell Res ; 14(3): 307-22, 2015 May.
Article em En | MEDLINE | ID: mdl-25840412
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Receptores Acoplados a Proteínas G Limite: Animals Idioma: En Revista: Stem Cell Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Receptores Acoplados a Proteínas G Limite: Animals Idioma: En Revista: Stem Cell Res Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido